We are live on
!
Find out more
PMEF
Point72 Middle East FZE Portfolio holdings
AUM
$3.38B
1-Year Est. Return
14.09%
This Fund
S&P 500
This Quarter
Est. Return
+3.95%
1 Year Est. Return
+14.09%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.93B
AUM Growth
+$650M
(+28%)
Cap. Flow
+$595M
Cap. Flow
% of AUM
20.29%
Top 10 Holdings %
Top 10 Hldgs %
12.64%
Holding
2,402
New
555
Increased
562
Reduced
449
Closed
831
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$118M |
| 2 |
Cigna
CI
|
+$29.5M |
| 3 |
Lowe's Companies
LOW
|
+$25.4M |
| 4 |
NVIDIA
NVDA
|
+$24.8M |
| 5 |
Visa
V
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$19.2M |
| 2 |
American International
AIG
|
+$14.2M |
| 3 |
Merck
MRK
|
+$13.6M |
| 4 |
Booking.com
BKNG
|
+$13M |
| 5 |
Zoetis
ZTS
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11% |
| 2 | Healthcare | 8.44% |
| 3 | Consumer Discretionary | 8.14% |
| 4 | Financials | 7.12% |
| 5 | Industrials | 6.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
NETGEAR
NTGR
$647M
| $16.1K | ﹤0.01% |
+869
| New | +$16.3K |
|
|
NPKI
1452
NPK International
NPKI
$1.18B
| $15.8K | ﹤0.01% |
4,100
+2,342
| +133% | +$10.3K |
|
1453
Inspire Medical Systems
INSP
$1.68B
| $15.6K | ﹤0.01% |
+67
| New | +$16.9K |
|
1454
Ovid Therapeutics
OVID
$523M
| $15.5K | ﹤0.01% |
+5,993
| New | +$14.2K |
|
1455
Sutro Biopharma
STRO
$353M
| $15.2K | ﹤0.01% |
+328
| New | +$20.8K |
|
1456
Byrna Technologies
BYRN
$97.6M
| $15.2K | ﹤0.01% |
+1,996
| New | +$17.7K |
|
1457
Cohu
COHU
$2.76B
| $14.6K | ﹤0.01% |
381
-4,465
| -92% | -$162K |
|
1458
Universal Electronics
UEIC
$66.6M
| $14.6K | ﹤0.01% |
+1,441
| New | +$25.1K |
|
|
KG
1459
Kestrel Group
KG
$60.5M
| $14.4K | ﹤0.01% |
+345
| New | +$16K |
|
1460
Tango Therapeutics
TNGX
$4.32B
| $14.2K | ﹤0.01% |
+3,583
| New | +$20.8K |
|
1461
Inogen
INGN
$154M
| $14.1K | ﹤0.01% |
+1,132
| New | +$21.7K |
|
1462
AdvanSix
ASIX
$446M
| $14K | ﹤0.01% |
+367
| New | +$14.7K |
|
1463
Aon
AON
$75.7B
| $13.9K | ﹤0.01% |
44
-12,068
| -100% | -$3.74M |
|
1464
Acumen Pharmaceuticals
ABOS
$184M
| $13.9K | ﹤0.01% |
+3,415
| New | +$17.8K |
|
1465
Astronics
ATRO
$4.57B
| $13.8K | ﹤0.01% |
+1,236
| New | +$13.8K |
|
1466
Oportun Financial
OPRT
$351M
| $13.5K | ﹤0.01% |
3,485
+1,164
| +50% | +$6.55K |
|
1467
Enviri
NVRI
$564M
| $13.3K | ﹤0.01% |
1,948
-4,701
| -71% | -$35.4K |
|
1468
Costamare
CMRE
$1.74B
| $13K | ﹤0.01% |
1,377
-9,178
| -87% | -$90.5K |
|
1469
Xometry
XMTR
$5.42B
| $12.9K | ﹤0.01% |
860
-6,237
| -88% | -$164K |
|
1470
CVRx
CVRX
$78.3M
| $12.7K | ﹤0.01% |
+1,365
| New | +$18.1K |
|
|
ATRI
1471
DELISTED
Atrion Corp
ATRI
| $12.6K | ﹤0.01% |
+20
| New | +$12.8K |
|
1472
Fulcrum Therapeutics
FULC
$283M
| $12.3K | ﹤0.01% |
+4,311
| New | +$38.6K |
|
|
ITOS
1473
DELISTED
iTeos Therapeutics
ITOS
| $12.2K | ﹤0.01% |
+900
| New | +$16.1K |
|
1474
Scansource
SCSC
$1.06B
| $12K | ﹤0.01% |
+394
| New | +$12.2K |
|
|
DZSI
1475
DELISTED
DZS Inc. Common Stock
DZSI
| $11.8K | ﹤0.01% |
+1,495
| New | +$16.6K |
|
Similar funds
CC
SS
GW
WMSA
GC
WP
BWM
DI
Point72 Middle East FZE's Q1 2023 Portfolio in Review
As of Q1 2023, Point72 Middle East FZE held 2,402 positions worth $2.93B, up 28% from $2.28B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Point72 Middle East FZE deployed $595M of net new capital in Q1 2023, opening 555 new positions and adding to 562 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 295,544 shares worth $121M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Merck, an estimated $13.6M trimmed.
- Point72 Middle East FZE's largest Q1 2023 buy was State Street SPDR S&P 500 ETF Trust: 295,544 shares worth $121M.
- Point72 Middle East FZE added most to NVIDIA in Q1 2023, an estimated $24.8M increase.
- Point72 Middle East FZE's biggest Q1 2023 reduction was Merck, cutting an estimated $13.6M.
- Point72 Middle East FZE fully exited Advanced Micro Devices in Q1 2023, selling an estimated $19.2M.
- Point72 Middle East FZE's ten largest holdings make up 13% of its $2.93B portfolio in Q1 2023.
- Point72 Middle East FZE opened 555 new positions and closed 831 in Q1 2023.
- Point72 Middle East FZE's portfolio value rose 28% quarter-over-quarter to $2.93B.
Based on Point72 Middle East FZE's 13F filing for Q1 2023, filed 15 May 2023.